Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1528 of 5804
-
Triple chemo cocktail aims to clear deadly bowel blockages in advanced stomach cancer
Disease control Recruiting nowThis is a multi-center, non-randomized, 3-cohort, phase II trial, evaluating a triplet combination of docetaxel, oxaliplatin and fluorouracil for gastric cancer with peritoneal carcinomatosis and inoperable malignant bowel obstruction.
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Brain zaps could help smokers kick the habit for good
Symptom relief CompletedSmoking cessation is a public health priority. Tobacco is directly responsible for 75,000 deaths per year in France. Without help, less than 5% of smokers are still abstinent after 12 months of smoking cessation. The use of nicotine replacement therapy only increases the chances …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New hope for advanced cancer: LBL-024 trial now recruiting
Disease control Recruiting nowTo evaluate the phase I/II clinical study of LBL-024 in the treatment of patients with advanced malignant tumors
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
AI predicts which autistic teens respond to brain zaps
Symptom relief Recruiting nowAutism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by disturbances in communication, poor social skills, and aberrant behaviors. Particularly detrimental are the presence of restricted and repetitive stereotyped behaviors and uncontrollable temper outbu…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can a computer program help people with both anxiety and alcohol problems?
Disease control Recruiting nowThis project is designed to determine if a computer-delivered cognitive-behavioral treatment can improve the otherwise poor alcohol use disorder treatment outcomes for individuals with a co-occurring anxiety disorder. In the past, the investigators showed that this treatment does…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can mindfulness and peer support boost opioid treatment success?
Disease control OngoingThe proposed research effort will: The purpose of this study is as follows: 1. Test the effectiveness of the Minds and Mentors Program in a group treatment trial in which individuals using medications for opioid use disorder (MOUD) will be randomized in blocks of five to receiv…
Phase: NA • Sponsor: University of Alabama, Tuscaloosa • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a tuberculosis vaccine help fight HIV? new study explores
Disease control CompletedA phase IIA randomized double-blind placebo-controlled single-centre study of the effect of Bacillus Calmette-Guérin (BCG) vaccination on the HIV latent reservoir
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Ketamine may ease chronic pain after mastectomy, major trial underway
Symptom relief OngoingThe study utilizes a 3-arm placebo-controlled RCT to study the effectiveness of ketamine in reducing chronic post-mastectomy pain. Participants randomized to the first arm will receive a 0.35 mg/kg dose after induction, followed by a 0.25 mg/kg/hr infusion during surgery (up to a…
Phase: PHASE3 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New combo tackles tough pancreatic cancer
Disease control CompletedThis study aims to evaluate cabozantinib and pembrolizumab for the treatment of metastatic pancreatic adenocarcinoma.
Phase: PHASE2 • Sponsor: Joseph Kim • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug shows promise for Long-Term control of rare nerve disease
Disease control OngoingThe purpose of this study is to evaluate the safety and tolerability of extended dosing with eplontersen in participants with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN).
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can CBD cool brain inflammation and ease back pain and depression?
Symptom relief Recruiting nowThis study will investigate whether cannabidiol (CBD), the primary centrally and peripherally active non-intoxicating compound in the cannabis plant, exerts anti-neuroinflammatory effects in patients with chronic low back pain (cLBP) with or without mild-to-moderate depression.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Meditation may ease pain and mood in veterans
Symptom relief CompletedChronic pain (CP) is a major health problem for military Veterans, and CP is often associated with comorbid mental health problems, including posttraumatic stress disorder (PTSD) and depression. CP with psychological comorbidity is associated with increased healthcare costs, medi…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a cheap Fat-Lowering drug shield kidneys in type 1 diabetes?
Prevention OngoingDiabetic kidney disease remains the leading cause of end-stage kidney disease (ESKD), rising in frequency in parallel with the epidemic of diabetes worldwide. The estimated lifetime risk of kidney disease in persons with type 1 diabetes (T1D) has been reported to be as high as 50…
Phase: PHASE2 • Sponsor: Alessandro Doria • Aim: Prevention
Last updated Jun 27, 2026 09:02 UTC
-
ER smokers get E-Cig kits in bold Quit-Smoking trial
Disease control CompletedThe Cessation of Smoking Trial in the Emergency Department (CoSTED) is an National Institute for Health Research (NIHR) Health Technology Assessment (HTA) funded randomised controlled trial (RCT). The research question is "in people attending the Emergency Department who smoke, d…
Phase: NA • Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New 'Star Homes' aim to slash childhood disease in tanzania
Prevention CompletedMalaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to find out if the type of house design can affect the general health of children living in the house.
Phase: NA • Sponsor: University of Oxford • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Brain zaps and pen to paper: new PTSD therapy for veterans?
Symptom relief Recruiting nowPost-traumatic stress disorder (PTSD) is prevalent and represents a high healthcare burden among Veterans. Repetitive transcranial magnetic stimulation (rTMS) is a brain-based therapy that may be effective for treating PTSD. The theorized mechanism of rTMS is enhancement of emoti…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can an old drug make immunotherapy work again for hodgkin lymphoma?
Disease control OngoingThis phase I trial tests the safety and best dose of CC-486 (an oral form of azacitidine) when given together with nivolumab in treating patients with Hodgkin lymphoma that does not respond (refractory) to PD1-based immunotherapy or has come back (relapsed). CC-486 is in a class …
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Custom-Made vaccine takes on melanoma in early trial
Disease control OngoingThis research study is studying the drugs called NeoVax (a new type of personalized neoantigen vaccine) in combination with CDX-301 and Nivolumab or Pembrolizumab as a possible treatment for melanoma. The names of the study drugs involved in this study are: * Personalized Neoan…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Diabetes drug could help stop liver damage in hepatitis b patients
Disease control OngoingChronic hepatitis B (CHB) affects 257million individuals worldwide. In 2017, it caused around 39.7 million cases of cirrhosis and 0.4 million cirrhosis-related deaths in 2017. However, there is no specific treatment for liver fibrosis/cirrhosis. Although nucleos(t)ide analogues (…
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Vitamin B12 shows promise in preventing chemo side effect
Prevention OngoingA multicenter, randomized, placebo-controlled, double-blind, phase III clinical trial will be conducted to explore the efficacy and safety of mecobalamin in the prevention of 2/3 HFS in patients with early breast cancer. 234 patients will be enrolled and will be randomized into m…
Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC